BIOA INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Lawsuit Overview - The law firm Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against BioAge Labs Inc for alleged violations of the Securities Act of 1933 [1] - Investors who purchased BioAge Labs stock pursuant to its IPO have until March 10 2025 to seek appointment as lead plaintiff [1] - The lawsuit is captioned Soto v BioAge Labs Inc No 25-cv-00196 (ND Cal) [1] IPO and Stock Performance - BioAge Labs sold 1265 million shares at $1800 per share in its IPO held on September 26 2024 [2] - The stock price fell more than 76% after the company announced discontinuation of its STRIDES Phase 2 study on December 6 2024 [4] - By the commencement of the lawsuit BioAge Labs stock was trading at or around $582 per share well below the IPO price [4] Allegations - The lawsuit alleges that BioAge Labs IPO offering documents were materially false and/or misleading [3] - The company allegedly represented there were no safety concerns and expected to meet primary endpoint goals in its STRIDES clinical trial [3] - The STRIDES Phase 2 study of investigational drug candidate azelaprag was discontinued after liver transaminitis was observed in some subjects [4] Lead Plaintiff Process - Any investor who purchased BioAge Labs stock pursuant to the IPO can seek appointment as lead plaintiff [5] - The lead plaintiff is generally the movant with the greatest financial interest in the relief sought [5] - The lead plaintiff acts on behalf of all class members and can select a law firm to litigate the case [5] Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm representing investors in securities fraud cases [6] - The firm has recovered $66 billion for investors in securities-related class action cases in the last four years [6] - Robbins Geller has 200 lawyers in 10 offices and has obtained many of the largest securities class action recoveries in history [6]